bpc-157 safety human studies adverse effects BPC-157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness Products The Hidden Risks of BPC‑157:

Prior to the meeting, more than a half-dozen people with connections to the peptide industry were added to the group, including doctors, pharmacists or consultants who work in the field

If your client does not feel the effects after 2 3 injections, then it is more than likely that they are not B12 deficient

Wellness injections: Some people who are not clinically deficient choose monthly B12 injections for energy support and general wellbeing

Some people ignore tiredness for months before asking for help

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions